Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prophylaxis of Hepatic Encephalopathy: A Double Blind, Randomized, Placebo Controlled Study With Supplementation With a Probiotic Preparation

NCT01110447 is registered in ClinicalTrials.gov with CD Pharma India Pvt. Ltd. as lead sponsor.

NCT NCT01110447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01110447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prophylaxis of Hepatic Encephalopathy: A Double Blind, Randomized, Placebo Controlled Study With Supplementation With a Probiotic Preparation
Lead sponsor
CD Pharma India Pvt. Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2010
Completion date
March 31, 2013
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy